Data / Form D filings / Antlia Bioscience, Inc.
Antlia Bioscience, Inc.: Form D filings
Antlia Bioscience, Inc., a biotechnology company in Encinitas, CA, filed 3 Form D notices with the SEC between 2020 and 2026. The latest, on June 5, 2026, reports $6 million sold of a $20 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1281 HYMETTUS AVE, Encinitas, CA, 92024
- Phone
- (619) 990-0290
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1829522
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | New notice | $20,000,000 | $6,000,000 | $14,000,000 | 3 | May 22, 2026 | sec.gov |
| Apr 26, 2022 | New notice | $2,500,000 | $680,000 | $1,820,000 | 10 | Apr 13, 2022 | sec.gov |
| Oct 23, 2020 | New notice | $600,000 | $207,000 | $393,000 | 7 | Oct 14, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ankit Mahadevia | Executive Officer, Director | |
| Ben Auspitz | Director | |
| Brian Laurence Johnson | Executive Officer, Director | |
| Carlos Garcia Echeverria | Director | |
| Nihal Sinha | Director | |
| Martin Taylor | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 1, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Antlia Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.